{"id":"https://openalex.org/W4409423230","doi":"https://doi.org/10.1055/a-2557-8927","title":"Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without Diabetes","display_name":"Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without Diabetes","publication_year":2025,"publication_date":"2025-04-14","ids":{"openalex":"https://openalex.org/W4409423230","doi":"https://doi.org/10.1055/a-2557-8927","pmid":"https://pubmed.ncbi.nlm.nih.gov/40228542"},"language":"en","primary_location":{"id":"doi:10.1055/a-2557-8927","doi":"https://doi.org/10.1055/a-2557-8927","is_oa":false,"landing_page_url":"https://doi.org/10.1055/a-2557-8927","pdf_url":null,"source":{"id":"https://openalex.org/S4210226141","display_name":"Drug Research","issn_l":"2194-9379","issn":["2194-9379","2194-9387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001087787","display_name":"Nitin Deshmukh","orcid":"https://orcid.org/0009-0008-6555-2486","observed_orcids":["https://orcid.org/0009-0008-6555-2486"]},"institutions":[{"id":"https://openalex.org/I4210102159","display_name":"Wockhardt (India)","ror":"https://ror.org/01djxaj77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210102159"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Nitin J. Deshmukh","raw_affiliation_strings":["D.S.T.S. Mandal\u2019s Collage of Pharmacy, Solapur, Maharashtra,\n                    India","Wockhardt Research Centre, D4 MIDC, Chikalthana, Aurangabad,\n                    Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D.S.T.S. Mandal\u2019s Collage of Pharmacy, Solapur, Maharashtra,\n                    India","institution_ids":[]},{"raw_affiliation_string":"Wockhardt Research Centre, D4 MIDC, Chikalthana, Aurangabad,\n                    Maharashtra, India","institution_ids":["https://openalex.org/I4210102159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095379812","display_name":"M. S. Kalshetti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"M. S. Kalshetti","raw_affiliation_strings":["D.S.T.S. Mandal\u2019s Collage of Pharmacy, Solapur, Maharashtra,\n                    India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D.S.T.S. Mandal\u2019s Collage of Pharmacy, Solapur, Maharashtra,\n                    India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000362174","display_name":"Mohan Patil","orcid":"https://orcid.org/0000-0001-6803-9858","observed_orcids":["https://orcid.org/0000-0001-6803-9858"]},"institutions":[{"id":"https://openalex.org/I205640436","display_name":"Curtin University","ror":"https://ror.org/02n415q13","country_code":"AU","type":"education","lineage":["https://openalex.org/I205640436"]},{"id":"https://openalex.org/I4210102159","display_name":"Wockhardt (India)","ror":"https://ror.org/01djxaj77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210102159"]}],"countries":["AU","IN"],"is_corresponding":false,"raw_author_name":"Mohan Patil","raw_affiliation_strings":["Curtin Medical School, Curtin Health Innovation Research Institute,\n                    Curtin University, Perth, Australia","Wockhardt Research Centre, D4 MIDC, Chikalthana, Aurangabad,\n                    Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curtin Medical School, Curtin Health Innovation Research Institute,\n                    Curtin University, Perth, Australia","institution_ids":["https://openalex.org/I205640436"]},{"raw_affiliation_string":"Wockhardt Research Centre, D4 MIDC, Chikalthana, Aurangabad,\n                    Maharashtra, India","institution_ids":["https://openalex.org/I4210102159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040604961","display_name":"Manohar Nandanwar","orcid":"https://orcid.org/0000-0003-2861-1404","observed_orcids":["https://orcid.org/0000-0003-2861-1404"]},"institutions":[{"id":"https://openalex.org/I4210102159","display_name":"Wockhardt (India)","ror":"https://ror.org/01djxaj77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210102159"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Manohar Nandanwar","raw_affiliation_strings":["Wockhardt Research Centre, D4 MIDC, Chikalthana, Aurangabad,\n                    Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wockhardt Research Centre, D4 MIDC, Chikalthana, Aurangabad,\n                    Maharashtra, India","institution_ids":["https://openalex.org/I4210102159"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054061739","display_name":"Ganesh V. Sangle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102159","display_name":"Wockhardt (India)","ror":"https://ror.org/01djxaj77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210102159"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ganesh V. Sangle","raw_affiliation_strings":["Kashiv BioSciences Private Limited, Ahmedabad, Gujarat","Wockhardt Research Centre, D4 MIDC, Chikalthana, Aurangabad,\n                    Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kashiv BioSciences Private Limited, Ahmedabad, Gujarat","institution_ids":[]},{"raw_affiliation_string":"Wockhardt Research Centre, D4 MIDC, Chikalthana, Aurangabad,\n                    Maharashtra, India","institution_ids":["https://openalex.org/I4210102159"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5095379812"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"05","first_page":"129","last_page":"139"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sotagliflozin","display_name":"sotagliflozin","score":1.0},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.8880000114440918},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9869999885559082},{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":0.9350000023841858},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8820000290870667},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6039999723434448},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hepatic-triglycerides","display_name":"hepatic triglycerides","score":0.9070000052452087},{"id":"https://openalex.org/keywords/hepatic-cholesterol","display_name":"liver cholesterol","score":0.800000011920929},{"id":"https://openalex.org/keywords/fgf21","display_name":"FGF21","score":0.8889999985694885},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9769999980926514},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.9229999780654907},{"id":"https://openalex.org/keywords/high-fat-diet","display_name":"high-fat diet","score":0.8659999966621399},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.5989999771118164},{"id":"https://openalex.org/keywords/liver-inflammation","display_name":"liver inflammation","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.7232518196105957},{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.7174476385116577},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6835172772407532},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.6645573377609253},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6239498853683472},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.5898174047470093},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5534765124320984},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5255107879638672},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5024013519287109},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.41134315729141235},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3541821837425232},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34189873933792114},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.33739668130874634}],"mesh":[{"descriptor_ui":"D000069476","descriptor_name":"Linagliptin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069476","descriptor_name":"Linagliptin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069476","descriptor_name":"Linagliptin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013311","descriptor_name":"Streptozocin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D059305","descriptor_name":"Diet, High-Fat","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1055/a-2557-8927","doi":"https://doi.org/10.1055/a-2557-8927","is_oa":false,"landing_page_url":"https://doi.org/10.1055/a-2557-8927","pdf_url":null,"source":{"id":"https://openalex.org/S4210226141","display_name":"Drug Research","issn_l":"2194-9379","issn":["2194-9379","2194-9387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Research","raw_type":"journal-article"},{"id":"pmid:40228542","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40228542","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W1979283687","https://openalex.org/W1981894899","https://openalex.org/W1988777910","https://openalex.org/W1990411608","https://openalex.org/W2013071753","https://openalex.org/W2032658955","https://openalex.org/W2040507318","https://openalex.org/W2067740038","https://openalex.org/W2072812733","https://openalex.org/W2095574383","https://openalex.org/W2098012175","https://openalex.org/W2131044927","https://openalex.org/W2134944069","https://openalex.org/W2140978167","https://openalex.org/W2167591543","https://openalex.org/W2367970782","https://openalex.org/W2411826498","https://openalex.org/W2501890046","https://openalex.org/W2506843278","https://openalex.org/W2567229113","https://openalex.org/W2573090827","https://openalex.org/W2578670173","https://openalex.org/W2619744261","https://openalex.org/W2625383462","https://openalex.org/W2810729752","https://openalex.org/W2839544824","https://openalex.org/W2890673765","https://openalex.org/W2912523003","https://openalex.org/W2916700999","https://openalex.org/W2921806734","https://openalex.org/W2965938694","https://openalex.org/W2967379665","https://openalex.org/W2973671909","https://openalex.org/W2981086540","https://openalex.org/W2981565698","https://openalex.org/W2988046746","https://openalex.org/W3011718752","https://openalex.org/W3013518851","https://openalex.org/W3082461370","https://openalex.org/W3088344065","https://openalex.org/W3118300923","https://openalex.org/W3135652267","https://openalex.org/W3155964814","https://openalex.org/W3160641467","https://openalex.org/W3166867894","https://openalex.org/W3167353726","https://openalex.org/W4205105466","https://openalex.org/W4206513048","https://openalex.org/W4210259668","https://openalex.org/W4214696772","https://openalex.org/W4292484706","https://openalex.org/W4294628976","https://openalex.org/W4312197462"],"related_works":["https://openalex.org/W2061475223","https://openalex.org/W2506843278","https://openalex.org/W4381378313","https://openalex.org/W2940160396","https://openalex.org/W4224243770","https://openalex.org/W4324085426","https://openalex.org/W4394760869","https://openalex.org/W4206141000","https://openalex.org/W4414474062","https://openalex.org/W3097435658"],"abstract_inverted_index":{"Sotagliflozin,":[0],"a":[1,58,68],"dual":[2],"SGLT1/2":[3],"inhibitor,":[4],"enhances":[5],"glucagon":[6],"like":[7],"peptide-1":[8],"(GLP-1)":[9],"levels":[10],"and":[11,33,41,95,102,109,112,116,125,133,139,142,146,157,175,206,216],"GLP-1":[12,208],"receptor":[13],"agonists":[14],"are":[15],"used":[16],"to":[17,73,213],"manage":[18],"non-alcoholic":[19,60],"fatty":[20,45],"liver":[21,46,199],"disease":[22,47],"(NAFLD).":[23],"Study":[24],"investigates":[25],"the":[26,84,162,218],"effects":[27],"of":[28,71,83,220],"sotagliflozin":[29,101,132],"on":[30],"NAFLD,":[31],"alone":[32],"combined":[34],"with":[35,223],"linagliptin,":[36],"comparing":[37],"outcomes":[38],"in":[39,194,225,233],"normoglycemic":[40,234],"hyperglycemic":[42,226],"animal":[43],"models.Obese":[44],"(FLD)":[48],"model":[49,63],"was":[50,64],"induced":[51],"by":[52,66,77,107,114,123,127,137,144,155,159],"high-fat":[53],"diet":[54],"(HFD)":[55],"feeding,":[56],"while":[57],"diabetic":[59],"steatohepatitis":[61],"(NASH)":[62],"developed":[65],"administering":[67],"single":[69],"dose":[70],"streptozotocin":[72],"neonatal":[74],"mice,":[75,100,131],"followed":[76],"HFD":[78],"feeding":[79],"post-weaning.":[80],"At":[81],"termination":[82],"study,":[85],"parameters":[86],"including":[87],"biochemical":[88],"markers,":[89],"inflammatory":[90],"cytokines,":[91],"hepatic":[92,105,170,202],"lipid":[93],"content,":[94],"histopathology":[96],"were":[97],"assessed.In":[98],"NASH":[99,227],"linagliptin":[103,134,224],"reduced":[104,135],"triglycerides":[106,122,136,154],"60%":[108],"44%,":[110],"respectively,":[111,141],"cholesterol":[113,126,143,158],"46%":[115,145],"49%.":[117],"Their":[118],"combination":[119,182,189],"further":[120],"decreased":[121],"68.5%":[124],"83.9%.":[128],"In":[129],"FLD":[130,235],"33%":[138],"17%,":[140],"21%.":[147],"Combination":[148],"treatment":[149,190],"offered":[150],"no":[151],"benefit,":[152],"reducing":[153],"38%":[156],"27%.":[160],"Both":[161],"treatments":[163],"improved":[164],"plasma":[165,204],"fibroblast":[166],"growth":[167],"factor":[168],"21,":[169],"interlukin-6,":[171],"glucose":[172,205],"tolerance,":[173],"steatosis":[174],"mitigated":[176],"fat":[177],"pad":[178],"weight,":[179],"but":[180],"their":[181],"did":[183],"not":[184],"show":[185],"additional":[186],"benefit.":[187],"However,":[188],"demonstrated":[191],"added":[192],"benefit":[193,219],"modulating":[195],"NAFLD":[196,215],"activity":[197],"score,":[198],"enzymes,":[200],"glycogenated":[201],"nuclei,":[203],"active":[207],"levels.Study":[209],"underscores":[210],"sotagliflozin's":[211],"potential":[212],"mitigate":[214],"highlights":[217],"combining":[221],"it":[222],"model,":[228],"which":[229],"showed":[230],"limited":[231],"efficacy":[232],"mice.":[236]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-04-15T00:00:00"}